Veronika Polishchuk

Contact Information

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Veronika Polishchuk

Biography

Veronika Polishchuk, MD, is a BMT and Apheresis specialist at Nationwide Children’s Hospital. After receiving her doctor of medicine from SUNY Downstate Medical College, Dr. Polishchuk spent her time as an intern and resident in the Department of Pediatrics and a fellowship in the Division of Pediatric Hematology, Oncology, Marrow and Blood Cell Transplantation at Albert Einstein College of Medicine Children’s Hospital at Montefiore. Dr. Polishchuk went on to complete a PBMT fellowship in the Division of Pediatric Blood and Marrow Transplantation at Duke University Medical Center Duke Children’s Hospital. She has been awarded Best Teaching Fellow Award and Best Teaching Resident Award from the Children’s Hospital at Montefiore and is a professional member of the American Society of Hematology and oncology, of Hematology, of Clinical Oncology and for Blood and Marrow Transplantation. Before coming to Nationwide Children’s, Dr. Polishchuk served as a PBMT specialist at Texas Children’s Hospital and assistant professor at the Baylor College of Medicine.

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Blood and Marrow Transplant Clinical Team

Physician Team

Hematology, Oncology and BMT Fellowship

Faculty

Bone Marrow Transplant Fellowship

Associate Program Director

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Research

Publications

                  Raina R, Abu-Arja R, Sethi S, Dua R, Chakraborty R, Dibb JT, Basu RK, Bissler J, Felix MB, Brophy P, Bunchman T, Alhasan K, Haffner D, Kim YH, Licht C, McCulloch M, Menon S, Onder AM, Khooblall P, Khooblall A, Polishchuk V, Rangarajan H, Sultana A, Kashtan C. Acute kidney injury in pediatric hematopoietic cell transplantation: critical appraisal and consensus. Pediatr Nephrol. 2022 Feb 28;  

                


                  Kapadia M, Lehmann L, Auletta J, Beatty L, Bhatt N, Blacken R, Demmel K, Dodd T, Desmond C, Fitch T, Flesch L, Hartley D, Huber J, Ingraham H, Jakubowski R, Klunk A, Krupski C, Kusnier K, Liberio N, Maakaron J, Mueller M, Myers KC, Pai A, Parker L, Patel S, Phelan R, Polishchuk V, Sigmund A, Sper C, Tarquini S, Juckett M, Jaglowski S, Dandoy C, Rotz S. Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes. Transplant Cell Ther. 2022 Feb 10;  

                


                  Wright M, Rangarajan H, Abu-Arja R, Auletta JJ, Lee D, Polishchuk V, Pai V, Taylor K, Bajwa RPS. Use of belatacept as alternative graft vs host disease prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2021 May 20;  e14041.

                


                  Davidson N, Rangarajan HG, Driest K, Bajwa RPS, Polishchuk V, Abu-Arja RF. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Case Rep Rheumatol. 2021; 2021: 9323141.

                


                  Giricz O, Mo Y, Dahlman KB, Cotto-Rios XM, Vardabasso C, Nguyen H, Matusow B, Bartenstein M, Polishchuk V, Johnson DB, Bhagat TD, Shellooe R, Burton E, Tsai J, Zhang C, Habets G, Greally JM, Yu Y, Kenny PA, Fields GB, Pradhan K, Stanley ER, Bernstein E, Bollag G, Gavathiotis E, West BL, Sosman JA, Verma AK. The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanoma. JCI Insight. 2018 Jul 25; 3: 

                


                  Khazal S, Polishchuk V, Soffer G, Prinzing S, Gill J, Mahadeo KM. Allogeneic hematopoietic stem cell transplantation is associated with cure and durable remission of late-onset primary isolated central nervous system hemophagocytic lymphohistiocytosis. Pediatr Transplant. 2018 Feb; 22:

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 08/27/2018

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Duke Children’s Hospital and Health Center

Date Completed: 06/30/2017

Fellowship

Children’s Hospital at Montefiore

Date Completed: 06/30/2016

Residency

Children’s Hospital at Montefiore

Date Completed: 06/30/2013

Medical School

Suny Downstate Medical Center

Date Completed: 05/31/2010

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Veronika Polishchuk

Biography

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Blood and Marrow Transplant Clinical Team

Physician Team

Hematology, Oncology and BMT Fellowship

Faculty

Bone Marrow Transplant Fellowship

Associate Program Director

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Research

Publications

                  Raina R, Abu-Arja R, Sethi S, Dua R, Chakraborty R, Dibb JT, Basu RK, Bissler J, Felix MB, Brophy P, Bunchman T, Alhasan K, Haffner D, Kim YH, Licht C, McCulloch M, Menon S, Onder AM, Khooblall P, Khooblall A, Polishchuk V, Rangarajan H, Sultana A, Kashtan C. Acute kidney injury in pediatric hematopoietic cell transplantation: critical appraisal and consensus. Pediatr Nephrol. 2022 Feb 28;  

                


                  Kapadia M, Lehmann L, Auletta J, Beatty L, Bhatt N, Blacken R, Demmel K, Dodd T, Desmond C, Fitch T, Flesch L, Hartley D, Huber J, Ingraham H, Jakubowski R, Klunk A, Krupski C, Kusnier K, Liberio N, Maakaron J, Mueller M, Myers KC, Pai A, Parker L, Patel S, Phelan R, Polishchuk V, Sigmund A, Sper C, Tarquini S, Juckett M, Jaglowski S, Dandoy C, Rotz S. Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes. Transplant Cell Ther. 2022 Feb 10;  

                


                  Wright M, Rangarajan H, Abu-Arja R, Auletta JJ, Lee D, Polishchuk V, Pai V, Taylor K, Bajwa RPS. Use of belatacept as alternative graft vs host disease prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2021 May 20;  e14041.

                


                  Davidson N, Rangarajan HG, Driest K, Bajwa RPS, Polishchuk V, Abu-Arja RF. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Case Rep Rheumatol. 2021; 2021: 9323141.

                


                  Giricz O, Mo Y, Dahlman KB, Cotto-Rios XM, Vardabasso C, Nguyen H, Matusow B, Bartenstein M, Polishchuk V, Johnson DB, Bhagat TD, Shellooe R, Burton E, Tsai J, Zhang C, Habets G, Greally JM, Yu Y, Kenny PA, Fields GB, Pradhan K, Stanley ER, Bernstein E, Bollag G, Gavathiotis E, West BL, Sosman JA, Verma AK. The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanoma. JCI Insight. 2018 Jul 25; 3: 

                


                  Khazal S, Polishchuk V, Soffer G, Prinzing S, Gill J, Mahadeo KM. Allogeneic hematopoietic stem cell transplantation is associated with cure and durable remission of late-onset primary isolated central nervous system hemophagocytic lymphohistiocytosis. Pediatr Transplant. 2018 Feb; 22:

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 08/27/2018

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Duke Children’s Hospital and Health Center

Date Completed: 06/30/2017

Fellowship

Children’s Hospital at Montefiore

Date Completed: 06/30/2016

Residency

Children’s Hospital at Montefiore

Date Completed: 06/30/2013

Medical School

Suny Downstate Medical Center

Date Completed: 05/31/2010

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Veronika Polishchuk

Contact Information

Call us at:
(614) 722-3550
Fax us at:
(614) 722-3369
PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Veronika Polishchuk

Biography

She has been awarded Best Teaching Fellow Award and Best Teaching Resident Award from the Children’s Hospital at Montefiore and is a professional member of the American Society of Hematology and oncology, of Hematology, of Clinical Oncology and for Blood and Marrow Transplantation.

Before coming to Nationwide Children’s, Dr. Polishchuk served as a PBMT specialist at Texas Children’s Hospital and assistant professor at the Baylor College of Medicine.

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Blood and Marrow Transplant Clinical Team

Physician Team

Hematology, Oncology and BMT Fellowship

Faculty

Bone Marrow Transplant Fellowship

Associate Program Director

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Blood and Marrow Transplant Clinical Team

Physician Team

Hematology, Oncology and BMT Fellowship

Faculty

Bone Marrow Transplant Fellowship

Associate Program Director

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Blood and Marrow Transplant Clinical Team

Physician Team

Hematology, Oncology and BMT Fellowship

Faculty

Bone Marrow Transplant Fellowship

Associate Program Director

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Hematology/Oncology & BMT

Physician Team

Blood and Marrow Transplant Clinical Team

Physician Team

Hematology, Oncology and BMT Fellowship

Faculty

Bone Marrow Transplant Fellowship

Associate Program Director

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Hematology/Oncology & BMT
Physician Team
Blood and Marrow Transplant Clinical Team
Physician Team
Hematology, Oncology and BMT Fellowship
Faculty
Bone Marrow Transplant Fellowship
Associate Program Director
Primary Department
Pediatrics
Primary Section
Hematology & Oncology

Research

Publications

                  Raina R, Abu-Arja R, Sethi S, Dua R, Chakraborty R, Dibb JT, Basu RK, Bissler J, Felix MB, Brophy P, Bunchman T, Alhasan K, Haffner D, Kim YH, Licht C, McCulloch M, Menon S, Onder AM, Khooblall P, Khooblall A, Polishchuk V, Rangarajan H, Sultana A, Kashtan C. Acute kidney injury in pediatric hematopoietic cell transplantation: critical appraisal and consensus. Pediatr Nephrol. 2022 Feb 28;  

                


                  Kapadia M, Lehmann L, Auletta J, Beatty L, Bhatt N, Blacken R, Demmel K, Dodd T, Desmond C, Fitch T, Flesch L, Hartley D, Huber J, Ingraham H, Jakubowski R, Klunk A, Krupski C, Kusnier K, Liberio N, Maakaron J, Mueller M, Myers KC, Pai A, Parker L, Patel S, Phelan R, Polishchuk V, Sigmund A, Sper C, Tarquini S, Juckett M, Jaglowski S, Dandoy C, Rotz S. Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes. Transplant Cell Ther. 2022 Feb 10;  

                


                  Wright M, Rangarajan H, Abu-Arja R, Auletta JJ, Lee D, Polishchuk V, Pai V, Taylor K, Bajwa RPS. Use of belatacept as alternative graft vs host disease prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2021 May 20;  e14041.

                


                  Davidson N, Rangarajan HG, Driest K, Bajwa RPS, Polishchuk V, Abu-Arja RF. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Case Rep Rheumatol. 2021; 2021: 9323141.

                


                  Giricz O, Mo Y, Dahlman KB, Cotto-Rios XM, Vardabasso C, Nguyen H, Matusow B, Bartenstein M, Polishchuk V, Johnson DB, Bhagat TD, Shellooe R, Burton E, Tsai J, Zhang C, Habets G, Greally JM, Yu Y, Kenny PA, Fields GB, Pradhan K, Stanley ER, Bernstein E, Bollag G, Gavathiotis E, West BL, Sosman JA, Verma AK. The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanoma. JCI Insight. 2018 Jul 25; 3: 

                


                  Khazal S, Polishchuk V, Soffer G, Prinzing S, Gill J, Mahadeo KM. Allogeneic hematopoietic stem cell transplantation is associated with cure and durable remission of late-onset primary isolated central nervous system hemophagocytic lymphohistiocytosis. Pediatr Transplant. 2018 Feb; 22:

View More Publications

Research

Publications

                  Raina R, Abu-Arja R, Sethi S, Dua R, Chakraborty R, Dibb JT, Basu RK, Bissler J, Felix MB, Brophy P, Bunchman T, Alhasan K, Haffner D, Kim YH, Licht C, McCulloch M, Menon S, Onder AM, Khooblall P, Khooblall A, Polishchuk V, Rangarajan H, Sultana A, Kashtan C. Acute kidney injury in pediatric hematopoietic cell transplantation: critical appraisal and consensus. Pediatr Nephrol. 2022 Feb 28;  

                


                  Kapadia M, Lehmann L, Auletta J, Beatty L, Bhatt N, Blacken R, Demmel K, Dodd T, Desmond C, Fitch T, Flesch L, Hartley D, Huber J, Ingraham H, Jakubowski R, Klunk A, Krupski C, Kusnier K, Liberio N, Maakaron J, Mueller M, Myers KC, Pai A, Parker L, Patel S, Phelan R, Polishchuk V, Sigmund A, Sper C, Tarquini S, Juckett M, Jaglowski S, Dandoy C, Rotz S. Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes. Transplant Cell Ther. 2022 Feb 10;  

                


                  Wright M, Rangarajan H, Abu-Arja R, Auletta JJ, Lee D, Polishchuk V, Pai V, Taylor K, Bajwa RPS. Use of belatacept as alternative graft vs host disease prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2021 May 20;  e14041.

                


                  Davidson N, Rangarajan HG, Driest K, Bajwa RPS, Polishchuk V, Abu-Arja RF. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Case Rep Rheumatol. 2021; 2021: 9323141.

                


                  Giricz O, Mo Y, Dahlman KB, Cotto-Rios XM, Vardabasso C, Nguyen H, Matusow B, Bartenstein M, Polishchuk V, Johnson DB, Bhagat TD, Shellooe R, Burton E, Tsai J, Zhang C, Habets G, Greally JM, Yu Y, Kenny PA, Fields GB, Pradhan K, Stanley ER, Bernstein E, Bollag G, Gavathiotis E, West BL, Sosman JA, Verma AK. The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanoma. JCI Insight. 2018 Jul 25; 3: 

                


                  Khazal S, Polishchuk V, Soffer G, Prinzing S, Gill J, Mahadeo KM. Allogeneic hematopoietic stem cell transplantation is associated with cure and durable remission of late-onset primary isolated central nervous system hemophagocytic lymphohistiocytosis. Pediatr Transplant. 2018 Feb; 22:

View More Publications

Research

Publications

                  Raina R, Abu-Arja R, Sethi S, Dua R, Chakraborty R, Dibb JT, Basu RK, Bissler J, Felix MB, Brophy P, Bunchman T, Alhasan K, Haffner D, Kim YH, Licht C, McCulloch M, Menon S, Onder AM, Khooblall P, Khooblall A, Polishchuk V, Rangarajan H, Sultana A, Kashtan C. Acute kidney injury in pediatric hematopoietic cell transplantation: critical appraisal and consensus. Pediatr Nephrol. 2022 Feb 28;  

                


                  Kapadia M, Lehmann L, Auletta J, Beatty L, Bhatt N, Blacken R, Demmel K, Dodd T, Desmond C, Fitch T, Flesch L, Hartley D, Huber J, Ingraham H, Jakubowski R, Klunk A, Krupski C, Kusnier K, Liberio N, Maakaron J, Mueller M, Myers KC, Pai A, Parker L, Patel S, Phelan R, Polishchuk V, Sigmund A, Sper C, Tarquini S, Juckett M, Jaglowski S, Dandoy C, Rotz S. Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes. Transplant Cell Ther. 2022 Feb 10;  

                


                  Wright M, Rangarajan H, Abu-Arja R, Auletta JJ, Lee D, Polishchuk V, Pai V, Taylor K, Bajwa RPS. Use of belatacept as alternative graft vs host disease prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2021 May 20;  e14041.

                


                  Davidson N, Rangarajan HG, Driest K, Bajwa RPS, Polishchuk V, Abu-Arja RF. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Case Rep Rheumatol. 2021; 2021: 9323141.

                


                  Giricz O, Mo Y, Dahlman KB, Cotto-Rios XM, Vardabasso C, Nguyen H, Matusow B, Bartenstein M, Polishchuk V, Johnson DB, Bhagat TD, Shellooe R, Burton E, Tsai J, Zhang C, Habets G, Greally JM, Yu Y, Kenny PA, Fields GB, Pradhan K, Stanley ER, Bernstein E, Bollag G, Gavathiotis E, West BL, Sosman JA, Verma AK. The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanoma. JCI Insight. 2018 Jul 25; 3: 

                


                  Khazal S, Polishchuk V, Soffer G, Prinzing S, Gill J, Mahadeo KM. Allogeneic hematopoietic stem cell transplantation is associated with cure and durable remission of late-onset primary isolated central nervous system hemophagocytic lymphohistiocytosis. Pediatr Transplant. 2018 Feb; 22:

View More Publications

Publications

                  Raina R, Abu-Arja R, Sethi S, Dua R, Chakraborty R, Dibb JT, Basu RK, Bissler J, Felix MB, Brophy P, Bunchman T, Alhasan K, Haffner D, Kim YH, Licht C, McCulloch M, Menon S, Onder AM, Khooblall P, Khooblall A, Polishchuk V, Rangarajan H, Sultana A, Kashtan C. Acute kidney injury in pediatric hematopoietic cell transplantation: critical appraisal and consensus. Pediatr Nephrol. 2022 Feb 28;  

                


                  Kapadia M, Lehmann L, Auletta J, Beatty L, Bhatt N, Blacken R, Demmel K, Dodd T, Desmond C, Fitch T, Flesch L, Hartley D, Huber J, Ingraham H, Jakubowski R, Klunk A, Krupski C, Kusnier K, Liberio N, Maakaron J, Mueller M, Myers KC, Pai A, Parker L, Patel S, Phelan R, Polishchuk V, Sigmund A, Sper C, Tarquini S, Juckett M, Jaglowski S, Dandoy C, Rotz S. Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes. Transplant Cell Ther. 2022 Feb 10;  

                


                  Wright M, Rangarajan H, Abu-Arja R, Auletta JJ, Lee D, Polishchuk V, Pai V, Taylor K, Bajwa RPS. Use of belatacept as alternative graft vs host disease prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2021 May 20;  e14041.

                


                  Davidson N, Rangarajan HG, Driest K, Bajwa RPS, Polishchuk V, Abu-Arja RF. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Case Rep Rheumatol. 2021; 2021: 9323141.

                


                  Giricz O, Mo Y, Dahlman KB, Cotto-Rios XM, Vardabasso C, Nguyen H, Matusow B, Bartenstein M, Polishchuk V, Johnson DB, Bhagat TD, Shellooe R, Burton E, Tsai J, Zhang C, Habets G, Greally JM, Yu Y, Kenny PA, Fields GB, Pradhan K, Stanley ER, Bernstein E, Bollag G, Gavathiotis E, West BL, Sosman JA, Verma AK. The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanoma. JCI Insight. 2018 Jul 25; 3: 

                


                  Khazal S, Polishchuk V, Soffer G, Prinzing S, Gill J, Mahadeo KM. Allogeneic hematopoietic stem cell transplantation is associated with cure and durable remission of late-onset primary isolated central nervous system hemophagocytic lymphohistiocytosis. Pediatr Transplant. 2018 Feb; 22:

View More Publications

                  Raina R, Abu-Arja R, Sethi S, Dua R, Chakraborty R, Dibb JT, Basu RK, Bissler J, Felix MB, Brophy P, Bunchman T, Alhasan K, Haffner D, Kim YH, Licht C, McCulloch M, Menon S, Onder AM, Khooblall P, Khooblall A, Polishchuk V, Rangarajan H, Sultana A, Kashtan C. Acute kidney injury in pediatric hematopoietic cell transplantation: critical appraisal and consensus. Pediatr Nephrol. 2022 Feb 28;  

                


                  Kapadia M, Lehmann L, Auletta J, Beatty L, Bhatt N, Blacken R, Demmel K, Dodd T, Desmond C, Fitch T, Flesch L, Hartley D, Huber J, Ingraham H, Jakubowski R, Klunk A, Krupski C, Kusnier K, Liberio N, Maakaron J, Mueller M, Myers KC, Pai A, Parker L, Patel S, Phelan R, Polishchuk V, Sigmund A, Sper C, Tarquini S, Juckett M, Jaglowski S, Dandoy C, Rotz S. Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes. Transplant Cell Ther. 2022 Feb 10;  

                


                  Wright M, Rangarajan H, Abu-Arja R, Auletta JJ, Lee D, Polishchuk V, Pai V, Taylor K, Bajwa RPS. Use of belatacept as alternative graft vs host disease prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2021 May 20;  e14041.

                


                  Davidson N, Rangarajan HG, Driest K, Bajwa RPS, Polishchuk V, Abu-Arja RF. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Case Rep Rheumatol. 2021; 2021: 9323141.

                


                  Giricz O, Mo Y, Dahlman KB, Cotto-Rios XM, Vardabasso C, Nguyen H, Matusow B, Bartenstein M, Polishchuk V, Johnson DB, Bhagat TD, Shellooe R, Burton E, Tsai J, Zhang C, Habets G, Greally JM, Yu Y, Kenny PA, Fields GB, Pradhan K, Stanley ER, Bernstein E, Bollag G, Gavathiotis E, West BL, Sosman JA, Verma AK. The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanoma. JCI Insight. 2018 Jul 25; 3: 

                


                  Khazal S, Polishchuk V, Soffer G, Prinzing S, Gill J, Mahadeo KM. Allogeneic hematopoietic stem cell transplantation is associated with cure and durable remission of late-onset primary isolated central nervous system hemophagocytic lymphohistiocytosis. Pediatr Transplant. 2018 Feb; 22:

View More Publications

Raina R, Abu-Arja R, Sethi S, Dua R, Chakraborty R, Dibb JT, Basu RK, Bissler J, Felix MB, Brophy P, Bunchman T, Alhasan K, Haffner D, Kim YH, Licht C, McCulloch M, Menon S, Onder AM, Khooblall P, Khooblall A, Polishchuk V, Rangarajan H, Sultana A, Kashtan C. Acute kidney injury in pediatric hematopoietic cell transplantation: critical appraisal and consensus. Pediatr Nephrol. 2022 Feb 28;
Kapadia M, Lehmann L, Auletta J, Beatty L, Bhatt N, Blacken R, Demmel K, Dodd T, Desmond C, Fitch T, Flesch L, Hartley D, Huber J, Ingraham H, Jakubowski R, Klunk A, Krupski C, Kusnier K, Liberio N, Maakaron J, Mueller M, Myers KC, Pai A, Parker L, Patel S, Phelan R, Polishchuk V, Sigmund A, Sper C, Tarquini S, Juckett M, Jaglowski S, Dandoy C, Rotz S. Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes. Transplant Cell Ther. 2022 Feb 10;
Wright M, Rangarajan H, Abu-Arja R, Auletta JJ, Lee D, Polishchuk V, Pai V, Taylor K, Bajwa RPS. Use of belatacept as alternative graft vs host disease prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2021 May 20; e14041.
Davidson N, Rangarajan HG, Driest K, Bajwa RPS, Polishchuk V, Abu-Arja RF. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Case Rep Rheumatol. 2021; 2021: 9323141.
Giricz O, Mo Y, Dahlman KB, Cotto-Rios XM, Vardabasso C, Nguyen H, Matusow B, Bartenstein M, Polishchuk V, Johnson DB, Bhagat TD, Shellooe R, Burton E, Tsai J, Zhang C, Habets G, Greally JM, Yu Y, Kenny PA, Fields GB, Pradhan K, Stanley ER, Bernstein E, Bollag G, Gavathiotis E, West BL, Sosman JA, Verma AK. The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanoma. JCI Insight. 2018 Jul 25; 3:
Khazal S, Polishchuk V, Soffer G, Prinzing S, Gill J, Mahadeo KM. Allogeneic hematopoietic stem cell transplantation is associated with cure and durable remission of late-onset primary isolated central nervous system hemophagocytic lymphohistiocytosis. Pediatr Transplant. 2018 Feb; 22:

Education

Date of Appointment at Nationwide Children’s Hospital: 08/27/2018

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Duke Children’s Hospital and Health Center

Date Completed: 06/30/2017

Fellowship

Children’s Hospital at Montefiore

Date Completed: 06/30/2016

Residency

Children’s Hospital at Montefiore

Date Completed: 06/30/2013

Medical School

Suny Downstate Medical Center

Date Completed: 05/31/2010

Education

Date of Appointment at Nationwide Children’s Hospital: 08/27/2018

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Duke Children’s Hospital and Health Center

Date Completed: 06/30/2017

Fellowship

Children’s Hospital at Montefiore

Date Completed: 06/30/2016

Residency

Children’s Hospital at Montefiore

Date Completed: 06/30/2013

Medical School

Suny Downstate Medical Center

Date Completed: 05/31/2010

Education

Date of Appointment at Nationwide Children’s Hospital: 08/27/2018

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Duke Children’s Hospital and Health Center

Date Completed: 06/30/2017

Fellowship

Children’s Hospital at Montefiore

Date Completed: 06/30/2016

Residency

Children’s Hospital at Montefiore

Date Completed: 06/30/2013

Medical School

Suny Downstate Medical Center

Date Completed: 05/31/2010

Date of Appointment at Nationwide Children’s Hospital: 08/27/2018

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Duke Children’s Hospital and Health Center

Date Completed: 06/30/2017

Fellowship

Children’s Hospital at Montefiore

Date Completed: 06/30/2016

Residency

Children’s Hospital at Montefiore

Date Completed: 06/30/2013

Medical School

Suny Downstate Medical Center

Date Completed: 05/31/2010

Date of Appointment at Nationwide Children’s Hospital: 08/27/2018

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Duke Children’s Hospital and Health Center

Date Completed: 06/30/2017

Fellowship

Children’s Hospital at Montefiore

Date Completed: 06/30/2016

Residency

Children’s Hospital at Montefiore

Date Completed: 06/30/2013

Medical School

Suny Downstate Medical Center

Date Completed: 05/31/2010

Pediatric Hematology Oncology
Pediatrics

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Call us at:
(614) 722-3550
Fax us at:
(614) 722-3369
Hematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Contact Information#

Contact Information